Toggle Main Menu Toggle Search

Open Access padlockePrints

Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy

Lookup NU author(s): Professor Heather Cordell

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background: IgE-mediated peanut allergy is a complex trait with strong heritability, but its genetic basis is currently unknown. Loss-of-function mutations within the filaggrin gene are associated with atopic dermatitis and other atopic diseases; therefore, filaggrin is a candidate gene in the etiology of peanut allergy. Objective: To investigate the association between filaggrin loss-of-function mutations and peanut allergy. Methods: Case-control study of 71 English, Dutch, and Irish oral food challenge-positive patients with peanut allergy and 1000 non peanut-sensitized English population controls. Replication was tested in 390 white Canadian patients with peanut allergy (defined by food challenge, or clinical history and skin prick test wheal to peanut >= 8 mm and/or peanut-specific IgE >= 15 kUL(-1)) and 891 white Canadian population controls. The most prevalent filaggrin loss-of-function mutations were assayed in each population: R501X and 2282del4 in the Europeans, and R501X, 2282del4, R2447X, and S3247X in the Canadians. The Fisher exact test and logistic regression were used to test for association; covariate analysis controlled for coexistent atopic dermatitis. Results: Filaggrin loss-of-function mutations showed a strong and significant association with peanut allergy in the food challenge-positive patients (P = 3.0 x 10(-6); odds ratio, 5.3; 95% CI, 2.8-10.2), and this association was replicated in the Canadian study (P = 5.4 x 10(-5); odds ratio, 1.9; 95% CI, 1.4-2.6). The association of filaggrin mutations with peanut allergy remains significant (P = .0008) after controlling for coexistent atopic dermatitis. Conclusion: Filaggrin mutations represent a significant risk factor for IgE-mediated peanut allergy, indicating a role for epithelial barrier dysfunction in the pathogenesis of this disease. (J Allergy Clin Immunol 2011;127:661-7.)


Publication metadata

Author(s): Brown SJ, Asai Y, Cordell HJ, Campbell LE, Zhao YW, Liao HH, Northstone K, Henderson J, Alizadehfar R, Ben-Shoshan M, Morgan K, Roberts G, Masthoff LJN, Pasmans SGMA, van den Akker PC, Wijmenga C, Hourihane JO, Palmer CNA, Lack G, Clarke A, Hull PR, Irvine AD, McLean WHI

Publication type: Article

Publication status: Published

Journal: Journal of Allergy and Clinical Immunology

Year: 2011

Volume: 127

Issue: 3

Pages: 661-667

Print publication date: 03/03/2011

ISSN (print): 0091-6749

ISSN (electronic): 1085-8725

Publisher: Mosby, Inc.

URL: http://dx.doi.org/10.1016/j.jaci.2011.01.031

DOI: 10.1016/j.jaci.2011.01.031


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
AllerGen
AllerGen Network of Centres of Excellence
Canadian Allergy, Asthma, and Immunology Foundation
Foundations of the McGill University Health Centre
Montreal Children's Hospital
National Eczema Society
British Skin Foundation
Bruce Katz Travel Fund
Canadian Dermatology Foundation
Canadian Institutes of Health Research
Department of Medicine
National Children's Research Centre, Dublin
University of Saskatchewan
086398/Z/08/ZWellcome Trust
087436Wellcome Trust
090066/B/09/ZWellcome Trust
092530/Z/10/ZWellcome Trust
G0700314Medical Research Council
T07001United Kingdom Food Standards Agency

Share